Tandem Diabetes Care, Inc. (TNDM)
USD 16.43
(-6.96%)
USD 16.43
(-6.96%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 157.93 Million USD | 42.14% |
| 2022 | 111.11 Million USD | 62.09% |
| 2021 | 68.55 Million USD | 7.58% |
| 2020 | 63.72 Million USD | 29.85% |
| 2019 | 49.07 Million USD | 146.65% |
| 2018 | 19.89 Million USD | -26.29% |
| 2017 | 26.99 Million USD | 27.36% |
| 2016 | 21.19 Million USD | 20.82% |
| 2015 | 17.54 Million USD | 47.26% |
| 2014 | 11.91 Million USD | 15.32% |
| 2013 | 10.33 Million USD | 65.0% |
| 2012 | 6.26 Million USD | 12421.62% |
| 2011 | 50 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 153.89 Million USD | -2.56% |
| 2024 Q2 | 161.66 Million USD | 5.05% |
| 2023 Q4 | 157.93 Million USD | 10.07% |
| 2023 Q3 | 143.49 Million USD | -2.78% |
| 2023 FY | 157.93 Million USD | 42.14% |
| 2023 Q1 | 131.55 Million USD | 18.4% |
| 2023 Q2 | 147.59 Million USD | 12.19% |
| 2022 FY | 111.11 Million USD | 62.09% |
| 2022 Q4 | 111.11 Million USD | 6.05% |
| 2022 Q1 | 79.98 Million USD | 16.68% |
| 2022 Q3 | 104.77 Million USD | 18.93% |
| 2022 Q2 | 88.09 Million USD | 10.14% |
| 2021 FY | 68.55 Million USD | 7.58% |
| 2021 Q2 | 66.7 Million USD | -0.17% |
| 2021 Q1 | 66.81 Million USD | 4.86% |
| 2021 Q4 | 68.55 Million USD | 4.29% |
| 2021 Q3 | 65.73 Million USD | -1.46% |
| 2020 Q4 | 63.72 Million USD | -9.8% |
| 2020 Q3 | 70.64 Million USD | 13.46% |
| 2020 Q1 | 60.46 Million USD | 23.22% |
| 2020 Q2 | 62.26 Million USD | 2.97% |
| 2020 FY | 63.72 Million USD | 29.85% |
| 2019 Q4 | 49.07 Million USD | 20.48% |
| 2019 Q3 | 40.73 Million USD | 48.98% |
| 2019 FY | 49.07 Million USD | 146.65% |
| 2019 Q1 | 22.82 Million USD | 14.73% |
| 2019 Q2 | 27.34 Million USD | 19.78% |
| 2018 Q3 | 24.36 Million USD | -2.19% |
| 2018 Q4 | 19.89 Million USD | -18.35% |
| 2018 FY | 19.89 Million USD | -26.29% |
| 2018 Q1 | 26.48 Million USD | -1.88% |
| 2018 Q2 | 24.91 Million USD | -5.94% |
| 2017 FY | 26.99 Million USD | 27.36% |
| 2017 Q4 | 26.99 Million USD | -9.98% |
| 2017 Q1 | 23.74 Million USD | 12.05% |
| 2017 Q3 | 29.98 Million USD | 16.12% |
| 2017 Q2 | 25.82 Million USD | 8.74% |
| 2016 Q1 | 20.19 Million USD | 15.12% |
| 2016 FY | 21.19 Million USD | 20.82% |
| 2016 Q4 | 21.19 Million USD | -7.43% |
| 2016 Q3 | 22.89 Million USD | 5.55% |
| 2016 Q2 | 21.69 Million USD | 7.41% |
| 2015 FY | 17.54 Million USD | 47.26% |
| 2015 Q4 | 17.54 Million USD | -0.05% |
| 2015 Q3 | 17.55 Million USD | 19.65% |
| 2015 Q2 | 14.67 Million USD | 8.02% |
| 2015 Q1 | 13.58 Million USD | 14.0% |
| 2014 Q1 | 10.16 Million USD | -1.6% |
| 2014 FY | 11.91 Million USD | 15.32% |
| 2014 Q4 | 11.91 Million USD | 0.18% |
| 2014 Q3 | 11.89 Million USD | 6.93% |
| 2014 Q2 | 11.12 Million USD | 9.41% |
| 2013 Q1 | - USD | -100.0% |
| 2013 Q2 | 9.78 Million USD | 0.0% |
| 2013 Q3 | 10.79 Million USD | 10.32% |
| 2013 Q4 | 10.33 Million USD | -4.34% |
| 2013 FY | 10.33 Million USD | 65.0% |
| 2012 FY | 6.26 Million USD | 12421.62% |
| 2012 Q4 | 6.26 Million USD | 0.0% |
| 2011 FY | 50 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | -4671.511% |
| BrainsWay Ltd. | 3.71 Million USD | -4149.045% |
| Cerus Corporation | 39.86 Million USD | -296.15% |
| Envoy Medical, Inc. | 1.4 Million USD | -11149.074% |
| electroCore, Inc. | 2.16 Million USD | -7211.898% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -34459.519% |
| IceCure Medical Ltd | 2.27 Million USD | -6842.286% |
| Inogen, Inc. | 21.84 Million USD | -623.155% |
| OrthoPediatrics Corp. | 105.85 Million USD | -49.207% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -56711.871% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -15793699900.0% |
| MaxCyte, Inc. | 12.22 Million USD | -1191.496% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -9046.828% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -100869.825% |
| Orthofix Medical Inc. | 222.16 Million USD | 28.91% |
| PAVmed Inc | 1.01 Million USD | -15429.71% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | -691.228% |
| RxSight, Inc. | 17.42 Million USD | -806.59% |
| Sight Sciences, Inc. | 7.84 Million USD | -1912.193% |
| SI-BONE, Inc. | 20.24 Million USD | -679.974% |
| TELA Bio, Inc. | 13.16 Million USD | -1099.947% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | -440.048% |
| Vivos Therapeutics, Inc. | 1.00 USD | -15793699900.0% |
| Acutus Medical, Inc. | 4.27 Million USD | -3591.842% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -68568.261% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -6603.608% |
| CVRx, Inc. | 10.98 Million USD | -1338.013% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -40388.777% |
| Bioventus Inc. | 91.33 Million USD | -72.924% |
| Venus Concept Inc. | 28.67 Million USD | -450.764% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -6105.776% |
| LivaNova PLC | 147.88 Million USD | -6.796% |
| 908 Devices Inc. | 14.93 Million USD | -957.283% |
| Alphatec Holdings, Inc. | 136.84 Million USD | -15.416% |
| Nemaura Medical Inc. | 1.75 Million USD | -8900.018% |
| NeuroPace, Inc. | 11.21 Million USD | -1308.391% |
| LENSAR, Inc. | 15.68 Million USD | -906.673% |
| Apyx Medical Corporation | 9.92 Million USD | -1491.626% |
| Cutera, Inc. | 72.1 Million USD | -119.05% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -5808.605% |
| BioSig Technologies, Inc. | -103 Thousand USD | 153436.893% |
| Anika Therapeutics, Inc. | 46.38 Million USD | -240.484% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | -1896.423% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 59.463% |
| Axonics, Inc. | 79.94 Million USD | -97.569% |
| Outset Medical, Inc. | 49.21 Million USD | -220.912% |
| IRIDEX Corporation | 9.9 Million USD | -1494.357% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | -297.266% |
| IRadimed Corporation | 12.82 Million USD | -1131.843% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -20791.138% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -59609.951% |
| Telesis Bio, Inc. | 4.02 Million USD | -3823.901% |
| Viemed Healthcare, Inc. | 4.6 Million USD | -3330.191% |
| Varex Imaging Corporation | 277.5 Million USD | 43.086% |
| Quipt Home Medical Corp. | 18.32 Million USD | -761.831% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | -843.302% |
| Dynatronics Corporation | 5.59 Million USD | -2723.342% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | -4121.786% |
| Semler Scientific, Inc. | 445 Thousand USD | -35391.461% |
| InMode Ltd. | 45.09 Million USD | -250.232% |
| Bruker Corporation | 968.3 Million USD | 83.689% |
| Cytosorbents Corporation | 3.68 Million USD | -4191.616% |
| DexCom, Inc. | 559.6 Million USD | 71.777% |
| Align Technology, Inc. | 296.9 Million USD | 46.805% |
| Viveve Medical, Inc. | 1.47 Million USD | -10629.416% |
| ZimVie Inc. | 79.6 Million USD | -98.413% |
| Movano Inc. | 1.51 Million USD | -10338.665% |
| Cytek Biosciences, Inc. | 60.87 Million USD | -159.436% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -100869.825% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Profound Medical Corp. | 6.95 Million USD | -2171.415% |
| Insulet Corporation | 402.6 Million USD | 60.771% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | -964.337% |
| iCAD, Inc. | 917 Thousand USD | -17123.228% |
| Nuwellis, Inc. | 1.99 Million USD | -7808.713% |
| Biotricity, Inc. | 1.87 Million USD | -8303.577% |
| iRhythm Technologies, Inc. | 13.97 Million USD | -1030.301% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -7399.383% |
| PAVmed Inc. | 1.01 Million USD | -15429.71% |
| BIOLASE, Inc. | 11.43 Million USD | -1281.413% |
| Beyond Air, Inc. | 2.12 Million USD | -7325.341% |
| FONAR Corporation | 2.71 Million USD | -5716.256% |
| AxoGen, Inc. | 23.02 Million USD | -586.086% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | -601.101% |
| Inari Medical, Inc. | 42.9 Million USD | -268.152% |
| UFP Technologies, Inc. | 70.19 Million USD | -125.01% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -25002.077% |
| Tenon Medical, Inc. | 554 Thousand USD | -28408.484% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -9387.273% |
| AdaptHealth Corp. | 113.64 Million USD | -38.978% |
| Sintx Technologies, Inc. | 888 Thousand USD | -17685.698% |
| NanoVibronix, Inc. | 2.73 Million USD | -5681.003% |
| Quanterix Corporation | 22.36 Million USD | -606.179% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | -963.764% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | -178.666% |
| TransMedics Group, Inc. | 44.23 Million USD | -257.041% |
| ReWalk Robotics Ltd. | 5.65 Million USD | -2693.862% |
| NeuroMetrix, Inc. | 1.55 Million USD | -10027.88% |
| Hyperfine, Inc. | 6.58 Million USD | -2299.529% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | -97.572% |
| Biomerica, Inc. | 2.37 Million USD | -6547.18% |
| Bone Biologics Corporation | -328.84 Thousand USD | 48127.94% |
| AVITA Medical, Inc. | 3.12 Million USD | -4959.793% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | -428.642% |